Free Trial

Chris Markoch, Editor & Contributing Author at MarketBeat

Articles by Chris Markoch - Page 32

On Second Thought, Investors Like What Dollar Tree Had to Say
March 4, 2021 11:00 PM ET

On Second Thought, Investors Like What Dollar Tree Had to Say

Chris Markoch

On the day after Dollar Tree (NASDAQ:DLTR) reported its fourth-quarter 2020 earnings report, the company received two downgrades from analysts.

NYSE:BIGNYSE:DG
Read On Second Thought, Investors Like What Dollar Tree Had to Say
You Should Steer Clear While Investors Are Frowning on Smile Direct Club
March 4, 2021 11:00 PM ET

You Should Steer Clear While Investors Are Frowning on Smile Direct Club

Chris Markoch

Shares of Smile Direct Club (NASDAQ:SDC) continue to sag in pre-market trading. This is despite the company’s earnings report that showed a beat on the top and bottom lines.

NASDAQ:SDC
Read You Should Steer Clear While Investors Are Frowning on Smile Direct Club
Ignore the Post-Earnings Dip and Take a Bite Out of Wendy’s Stock
March 4, 2021 4:00 AM ET

Ignore the Post-Earnings Dip and Take a Bite Out of Wendy’s Stock

Chris Markoch

Wendy’s (NYSE:WEN) continues to buck the trend of the pandemic. Fast food stocks would seem to have done well during the pandemic. They remained open for starters.

NYSE:WENNYSE:MCDNASDAQ:BYND
Read Ignore the Post-Earnings Dip and Take a Bite Out of Wendy’s Stock
AutoZone Beats Estimates Again, Price Target Raised
March 2, 2021 11:00 PM ET

AutoZone Beats Estimates Again, Price Target Raised

Chris Markoch

AutoZone (NYSE:AZO) was a pandemic winner. Despite many Americans not driving nearly as much as they were accustomed to, the company continues to deliver solid numbers. The double beat on March 1 is becoming yawn-inducing.

NYSE:AZO
Read AutoZone Beats Estimates Again, Price Target Raised
Guardion Health Sciences Stock Needs to Give Investors More Than Survival
February 26, 2021 4:23 AM ET

Guardion Health Sciences Stock Needs to Give Investors More Than Survival

Chris Markoch

Let me start by saying that Guardion Health Sciences (NASDAQ:GSHI) is one of the riskiest penny stocks you can buy. The company is a biotech/neutraceutical company that has been trading below $1 for the better part of 18 months

NASDAQ:GSHI
Read Guardion Health Sciences Stock Needs to Give Investors More Than Survival
Wait For a Better Price Before Placing a Bet On Churchill Downs
February 26, 2021 4:05 AM ET

Wait For a Better Price Before Placing a Bet On Churchill Downs

Chris Markoch

Churchill Downs (NASDAQ:CHDN) stock hit a record high share price the day before it released fourth quarter and full year 2020 earnings.

NASDAQ:CHDN
Read Wait For a Better Price Before Placing a Bet On Churchill Downs
It’s Okay to Take the Over on DraftKings Stock
February 25, 2021 11:00 PM ET

It’s Okay to Take the Over on DraftKings Stock

Chris Markoch

DraftKings (NASDAQ:DKNG) may have picked the wrong day to deliver a stellar earnings report. The online sports betting company delivered a sound beat on both the top and bottom lines before the market opened.

NASDAQ:DKNGNASDAQ:PENNNYSE:MGM
Read It’s Okay to Take the Over on DraftKings Stock
Should You Invest in AIM ImmunoTech Stock For the Long Haul?
February 24, 2021 4:08 AM ET

Should You Invest in AIM ImmunoTech Stock For the Long Haul?

Chris Markoch

Penny stock investors have made a nice profit on AIM ImmunoTech (NYSEAMERICAN:AIM) in 2020. In the last 12 months, AIM stock is up 115%.

NYSEAMERICAN:AIM
Read Should You Invest in AIM ImmunoTech Stock For the Long Haul?
For Republic Services (NYSE:RSG) the Future Looks Electric
February 23, 2021 4:46 AM ET

For Republic Services (NYSE:RSG) the Future Looks Electric

Chris Markoch

Republic Services (NYSE:RSG) reported its 2020 fourth quarter and full-year earnings. The company recorded a double beat with earnings per share (EPS) coming at $1.00 well above the 80 cents projected by analysts.

NYSE:RSGNASDAQ:NKLANYSE:RMO
Read For Republic Services (NYSE:RSG) the Future Looks Electric
Hold On to Six Flags Stock But Wait For More Thrills Before You Buy
February 22, 2021 11:00 PM ET

Hold On to Six Flags Stock But Wait For More Thrills Before You Buy

Chris Markoch

Six Flags (NYSE:SIX) reports earnings on February 24 and the news is not likely to be good. Analysts forecast negative earnings per share (EPS) of $1.02 on revenue of $87.04 million.

NYSE:SIXNYSE:DISNYSE:FUN
Read Hold On to Six Flags Stock But Wait For More Thrills Before You Buy
Here’s Why Palantir Stock Is a Momentum Buy After Earnings
February 21, 2021 11:00 PM ET

Here’s Why Palantir Stock Is a Momentum Buy After Earnings

Chris Markoch

Shares of Palantir (NYSE:PLTR) stock got a big lift on February 19, 2021. First, the company got upgraded by Goldman Sachs (NYSE:GS) analyst Christopher Merwin.

NYSE:PLTRNYSE:PCGNYSE:PCG
Read Here’s Why Palantir Stock Is a Momentum Buy After Earnings
The Time Is Now to Buy Roku Stock
February 21, 2021 11:00 PM ET

The Time Is Now to Buy Roku Stock

Chris Markoch

Since posting a surprising profit in its fourth-quarter earnings report, Roku (NASDAQ:ROKU) stock is continuing its spectacular rally. In the last six months, ROKU stock has climbed 217%.

NASDAQ:ROKU
Read The Time Is Now to Buy Roku Stock
Home Depot Stock Remains a Buy For Growth and Value
February 21, 2021 11:00 PM ET

Home Depot Stock Remains a Buy For Growth and Value

Chris Markoch

It’s setting up to be another strong quarter for The Home Depot (NYSE:HD). The home improvement retailer is expecting to report earnings per share of $2.61 on revenue of $30.45 billion.

NYSE:HDNASDAQ:AMZN
Read Home Depot Stock Remains a Buy For Growth and Value
Bullish Case For VistaGen Therapeutics Is Its Pipeline Not Its Stock Price
February 21, 2021 11:00 PM ET

Bullish Case For VistaGen Therapeutics Is Its Pipeline Not Its Stock Price

Chris Markoch

VistaGen Therapeutics (NASDAQ:VTGN) operates in the penny stock sector which can be the wild, wild west of the stock market. For every diamond in the rough, there are just as many failing companies or companies that will never be more than just penny stocks.

NASDAQ:VTGN
Read Bullish Case For VistaGen Therapeutics Is Its Pipeline Not Its Stock Price
Buy Into the Strength of CVS As the Vaccines Roll Out
February 15, 2021 11:00 PM ET

Buy Into the Strength of CVS As the Vaccines Roll Out

Chris Markoch

Shares of CVS (NYSE: CVS) stock are sharply down in early trading after the pharmacy chain released its fourth-quarter earnings. The nation’s largest pharmacy health care provider posted earnings per share (EPS) of $1.30

NYSE:CVS
Read Buy Into the Strength of CVS As the Vaccines Roll Out
Newell Brands Will Continue to Show Strength Post Earnings
February 10, 2021 11:00 PM ET

Newell Brands Will Continue to Show Strength Post Earnings

Chris Markoch

Newell Brands (NASDAQ:NWL) is expected to post another solid earnings report when it updates shareholders on Friday, February 12. The whisper number is projecting that the company will post earnings of 67 cents per share

NASDAQ:NWL
Read Newell Brands Will Continue to Show Strength Post Earnings
Bloom Energy Has a Bright Future, But It’s Not Here Yet
February 8, 2021 11:00 PM ET

Bloom Energy Has a Bright Future, But It’s Not Here Yet

Chris Markoch

Bloom Energy (NYSE:BE) will report earnings on February 10. The whisper number shows the company will deliver a five cent beat on the bottom line and generate 5 cents per share on $221.08 million

NYSE:BE
Read Bloom Energy Has a Bright Future, But It’s Not Here Yet
Canopy Growth May Go Higher and Still Not Be a Buy
February 7, 2021 11:00 PM ET

Canopy Growth May Go Higher and Still Not Be a Buy

Chris Markoch

Canopy Growth (NASDAQ:CGC) stock is up 67% since the start of the year. And the stock continues to move higher with the cannabis company scheduled to deliver its third-quarter earnings on February 9, 2021.

NASDAQ:CGCOTCMKTS:TCNNFOTCMKTS:JUSHF
Read Canopy Growth May Go Higher and Still Not Be a Buy
MarketBeat: Week in Review 2/1 – 2/5
February 6, 2021 4:00 AM ET

MarketBeat: Week in Review 2/1 – 2/5

Chris Markoch

Earnings season has remained largely positive and next week another blizzard of companies will report. This is always a time when the market finds direction and the MarketBeat staff will continue to bring you insight on stocks of interest.

Read MarketBeat: Week in Review 2/1 – 2/5
Is It Time to Take Some Profits on Penn National Gaming (NASDAQ:PENN)?
February 2, 2021 11:00 PM ET

Is It Time to Take Some Profits on Penn National Gaming (NASDAQ:PENN)?

Chris Markoch

Penn National Gaming (NASDAQ:PENN) was one of the biggest winners as the country began to reopen this summer. And in the case of Penn and other sports betting sites, reopening meant the return of live sports.

NASDAQ:PENNNASDAQ:DFKGNYSE:MGM
Read Is It Time to Take Some Profits on Penn National Gaming (NASDAQ:PENN)?
AbbVie (NYSE:ABBV) Is a Classic Buy the Dip Candidate
January 31, 2021 11:00 PM ET

AbbVie (NYSE:ABBV) Is a Classic Buy the Dip Candidate

Chris Markoch

AbbVie (NYSE:ABBV) will report earnings before the market opens on February 3, 2021. The biopharmaceutical giant is expected to post earnings per share and revenue that mark both a sequential and year-over-year gain

NYSE:ABBV
Read AbbVie (NYSE:ABBV) Is a Classic Buy the Dip Candidate
NextEra Energy Partners (NYSE:NEP) Stock Is Falling, You Can Blame GameStop (NYSE:GME)
January 26, 2021 11:00 PM ET

NextEra Energy Partners (NYSE:NEP) Stock Is Falling, You Can Blame GameStop (NYSE:GME)

Chris Markoch

Shares of NextEra Energy Partners (NYSE:NEP) are trading down over 10% after reaching a 52-week high post earnings. The question is why? On January 25, the company reported revenue that fell short of analysts’ expectations but posted a significant beat in earnings

NYSE:NEPNYSE:GME
Read NextEra Energy Partners (NYSE:NEP) Stock Is Falling, You Can Blame GameStop (NYSE:GME)
Buy Johnson & Johnson (NYSE:JNJ) Before Good News Gets Even Better
January 25, 2021 11:00 PM ET

Buy Johnson & Johnson (NYSE:JNJ) Before Good News Gets Even Better

Chris Markoch

In what many analysts are calling a frothy market, Johnson & Johnson (NYSE:JNJ) must be wondering what gives? The iconic big pharma company is being held to a mighty high standard.

NYSE:JNJNYSE:PFENASDAQ:MRNA
Read Buy Johnson & Johnson (NYSE:JNJ) Before Good News Gets Even Better
It May Be Time to Buy Region’s Financial (NYSE:RF), But Not Quite Yet
January 20, 2021 11:00 PM ET

It May Be Time to Buy Region’s Financial (NYSE:RF), But Not Quite Yet

Chris Markoch

Region’s Financial (NYSE:RF) has had a great run over the last six months. The bank’s stock price has increased 66%. And the bank is expected to present investors with solid results when it reports fourth quarter 2020 earnings

NYSE:RF
Read It May Be Time to Buy Region’s Financial (NYSE:RF), But Not Quite Yet